Stroke care within the golden hour [2]

JAMA Neurology

Volumn 72, Issue 4, 2015, Pages 475-476

  Fischer, Kyle ^a   McDonough, Vince ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Abrazo Health Care   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR;

BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DISEASE DURATION; DRUG EFFICACY; DRUG INDICATION; EARLY INTERVENTION; EMERGENCY CARE; FIBRINOLYTIC THERAPY; HUMAN; LETTER; ONSET AGE; PATIENT SAFETY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; EMERGENCY HEALTH SERVICE; FEMALE; MALE; PROCEDURES; STROKE;

EMERGENCY MEDICAL SERVICES; FEMALE; HUMANS; MALE; STROKE; THROMBOLYTIC THERAPY;

EID: 84928165362     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2014.4571     Document Type: Letter

References (2)

1. Ebinger M, Kunz A, Wendt M, et al. Effects of golden hour thrombolysis: a Prehospital Acute Neurological Treatment and Optimization of Medical Care in Stroke (PHANTOM-S) Substudy. JAMA Neurol. 2015;72(1):25-30.
2. ACEP Now. ACEP to reconsider clinical policy on use of intravenous tPA to manage acute ischemic stroke in the ED. February 11, 2014. http://www.acepnow.com/article/acep-council-votes-reconsider-clinical-policy-use-intravenous-tpa-manage-acute-ischemic-stroke-ed/. Accessed December 1, 2014.